Esperion Therapeutics (ESPR) Q4 2023 Earnings

27FebConfirmed
Q1 2023
Q2 2023
Q3 2023
Q4 2023
-0.79
-0.65
-0.51
-0.37

Details

Expected EPS
-0.481692
Actual EPS
-0.5
Surprise EPS
-0.02
Surprise Percent
+3.8%

Description

Esperion Therapeutics (ESPR) has reported earnings of -0.5 per share for Q4 2023.

0 Comments

Share your thoughts